Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

# Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 ## What the Bill Would Do This bill, introduced in the Senate, aims to address uterine fibroids—common noncancerous tumors that grow in the uterus and affect many women. While specific provisions aren't detailed in the available information, bills with this title typically focus on improving diagnosis, treatment options, and research funding for uterine fibroids and related gynecological health issues. The legislation would likely increase awareness and access to care for this condition, which can cause pain, heavy bleeding, and other complications. ## Who It Affects The bill primarily affects women diagnosed with or at risk for uterine fibroids, as well as healthcare providers and researchers in gynecology.

It may also impact the broader medical and pharmaceutical industries through changes in research funding or treatment coverage requirements. ## Current Status As of now, the bill is in committee, meaning it has been introduced but hasn't yet been debated or voted on by the full Senate. It was sponsored by Senator Angela Alsobrooks (D-MD). The bill would need to advance through committee review and pass both chambers of Congress before becoming law.